【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Drug Delivery Devices 11
3.1.1 Metered Dose Inhaler Devices 11
3.1.2 Needle Free Injections 11
4 Company Snapshot 12
4.1 Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
5 Business Description 13
5.1 Business Overview 13
5.2 Bespak – Drug Delivery Device 14
5.2.1 Overview 14
5.2.2 Financials 14
5.2.3 Capital Expenditure 14
5.2.4 Market View 14
5.3 King Systems – Anaesthesia Products 14
5.3.1 Overview 14
5.3.2 Financials 14
5.3.3 Capital Expenditure 14
5.3.4 Market View 14
5.4 Major Products and Services 15
5.4.1 Overview 15
6 History 16
7 SWOT Analysis 19
7.1 Overview 19
7.2 Consort Medical plc Strengths 20
7.2.1 Successful Integration of The Medical House 20
7.2.2 Focused Research and Development Activities 20
7.2.3 Geographical Diversity 20
7.2.4 Strong Liquidity Position 20
7.3 Consort Medical plc Weaknesses 21
7.3.1 Product Recalls 21
7.3.2 High Debt 21
7.4 Consort Medical plc Opportunities 22
7.4.1 Expansion in New Markets 22
7.4.2 Global Anesthesia and Respiratory Devices Market 22
7.4.3 Growing Aged Population 22
7.4.4 Emerging Inhaled Drug Delivery Market 23
7.5 Consort Medical plc Threats 24
7.5.1 Rapid Technological Changes 24
7.5.2 Stringent Government Regulations 24
7.5.3 Intense Competition 24
7.5.4 Industry Consolidation Challenges 24
8 Competitors 25
9 Competitive Landscape 26
9.1 Drug Delivery Devices (Metered Dose Inhaler Devices), Global, Market Share (%), 2011 26
9.2 Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Region, Market Share (2011) 28
9.3 Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Country, Market Share (2011) 29
9.4 Drug Delivery Devices (Needle Free Injections), Global, Market Share (%), 2011 31
9.5 Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Region, Market Share (2011) 32
9.6 Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Country, Market Share (2011) 33
9.7 Consort Medical plc, Drug Delivery Devices, Global, Category Revenue Share (2011) 35
9.8 Consort Medical plc, Asia-Pacific, Category Revenue Share (2011) 37
9.8.1 Consort Medical plc, Australia, Category Revenue Share (2011) 39
9.8.2 Consort Medical plc, China, Category Revenue Share (2011) 41
9.8.3 Consort Medical plc, Japan, Category Revenue Share (2011) 43
9.8.4 Consort Medical plc, Other Asia-Pacific, Category Revenue Share (2011) 45
9.9 Consort Medical plc, Europe, Category Revenue Share (2011) 46
9.9.1 Consort Medical plc, France, Category Revenue Share (2011) 48
9.9.2 Consort Medical plc, Germany, Category Revenue Share (2011) 50
9.9.3 Consort Medical plc, Italy, Category Revenue Share (2011) 52
9.9.4 Consort Medical plc, Spain, Category Revenue Share (2011) 54
9.9.5 Consort Medical plc, United Kingdom, Category Revenue Share (2011) 56
9.9.6 Consort Medical plc, Other Europe, Category Revenue Share (2011) 58
9.10 Consort Medical plc, Middle East and Africa, Category Revenue Share (2011) 60
9.11 Consort Medical plc, North America, Category Revenue Share (2011) 62
9.11.1 Consort Medical plc, Canada, Category Revenue Share (2011) 64
9.11.2 Consort Medical plc, United States, Category Revenue Share (2011) 66
9.12 Consort Medical plc, South and Central America, Category Revenue Share (2011) 68
9.12.1 Consort Medical plc, Brazil, Category Revenue Share (2011) 70
9.12.2 Consort Medical plc, Other South and Central America, Category Revenue Share (2011) 72
10 Key Employees 74
11 Key Employee Biographies 75
12 Company Statement 76
13 Locations And Subsidiaries 77
13.1 Head Office 77
13.2 Other Locations & Subsidiaries 77
14 Financial Deals Landscape 79
14.1 Consort Medical plc, Deals Volume Summary, 2007 to 2012 79
15 Consort Medical plc, Deals Summary By Region, 2007 to 2012 80
16 Consort Medical plc Detailed Deal Summary 82
16.1 Venture Financing 82
16.1.1 Atlas Genetics Raises $27 Million In Series B Financing 82
16.2 Partnerships 84
16.2.1 Consort Medical Enters Into Co-Development Agreement With Atlas Genetics 84
16.2.2 King Systems Enters Into Distribution Agreement With Beijing Gloryway Technology 85
16.2.3 Bespak Enters Into Co-Development Agreement With Zogenix 86
16.3 Acquisition 87
16.3.1 Ambu To Acquire King Systems From Consort Medical For Up To $170 Million 87
16.3.2 Consort Medical Completes The Acquisition Of Medical House 89
16.3.3 King Systems Acquires Majority Interest In Emergent Respiratory Products 91
17 Recent Developments 92
17.1 Strategy And Business Planning 92
17.1.1 Aug 03, 2006: Bespak To Withdraw From Consumer Dispensers Business 92
17.2 Financial Announcements 92
17.2.1 Dec 05, 2012: Consort Medical Reports Revenue Of £69.9m In H1 Fiscal 2013 92
17.2.2 Jul 28, 2011: Consort Medical Reports Total Revenues Of £132.4m In Fiscal 2011 93
17.2.3 Dec 02, 2010: Consort Medical Reports Total Revenues Of GBP69.6 Million In H1 Fiscal 2011 94
17.2.4 Jun 17, 2010: Consort Medical Reports Preliminary Fiscal 2010 Results 94
17.2.5 Dec 10, 2009: Consort Medical Reports Total Revenues Of GBP61.5 Million In H1 Fiscal 2010 95
17.2.6 Jun 24, 2009: Consort Medical Reports Preliminary Results For Fiscal 2009 97
17.2.7 Dec 11, 2008: Consort Medical Declares Interim Dividend 98
17.2.8 Dec 11, 2008: Consort Medical 1H Fiscal 2009 Results 98
17.2.9 Jan 18, 2007: Bespak Declares Interim Results 100
17.2.10 Nov 07, 2006: Bespak Sees To Beat Own Expectations 102
17.2.11 Jul 12, 2006: Bespak Declares 2006 Results 103
17.3 Corporate Communications 106
17.3.1 Dec 02, 2010: Consort Appoints Nick Higgins As Executive Director 106
17.3.2 May 21, 2010: Consort Medical Appoints Keyvan Djamarani As Group Director, Operations 106
17.3.3 Oct 13, 2009: Consort Medical Announces Departure Of Paul Boughton As Corporate Development Director 106
17.3.4 May 06, 2009: Consort Medical Appoints Dr William Jenkins As An Independent Non-Executive Director 107
17.3.5 Feb 13, 2009: Consort Medical Appoints New Chairman 107
17.3.6 Jun 24, 2008: Consort Medical Appoints Group Finance Director 108
17.3.7 Dec 05, 2007: Consort Medical Appoints CEO 108
17.3.8 Feb 16, 2007: Bespak Appoints Head Of Corporate Communications 108
17.3.9 Sep 28, 2006: Bespak To Hold Its AGM 109
17.3.10 Aug 31, 2006: Bespak Appoints Non-Executive Director 109
17.3.11 Jul 27, 2006: Bespak Appoints Group Finance Director 110
17.4 Product News 110
17.4.1 Oct 03, 2011: Bespak Wins Contract To Develop Unidose Nasal Drug Delivery Device 110
17.5 Other Significant Developments 111
17.5.1 May 03, 2007: Bespak Expects Strong Financials 111
17.5.2 Apr 03, 2007: Bespak To Raise Funds For The British Lung Foundation 111
18 Appendix 112
18.1 Research Methodology 113
18.2 Secondary Research 113
18.3 Primary Research 113
18.4 Models 114
18.5 Forecasts 114
18.6 Expert Panels 114
18.7 GlobalData Consulting 114
18.8 Currency Conversion 115
18.9 Contact Us 116
18.10 Disclaimer 116
【レポート販売概要】
■ タイトル：Consort Medical plc：市場シェア分析■ 英文：Consort Medical plc Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160484
■ 調査対象地域：グローバル
- ベータグルカン市場動向Product Synopsis This forecast report on Beta-Glucans covers an in-depth analysis of Beta-Glucan ingredients manufacturers and ingredients characteristics in relation to raw material use and extraction methods. The report investigates health benefits of Beta-Glucans and their regulatory status. The use for this ingredient category for food and beverage products is discussed and product case storie …
- 麻酔装置の世界市場2019-2023About this market The increasing number of surgeries requiring general anesthesia is one of the key factors expected to trigger the anesthesia devices market growth during the forecast period. General anesthesia is administered to the patients by medical practitioners for inducing unconsciousness during surgery and for post-surgery pain management. Anesthesia devices are also used for major operat …
- リン（燐）及び誘導体の世界市場：リン酸アンモニウム、工業用リン、塩化リン、五酸化リン、五硫化リンPhosphorus & derivatives are used in various applications to improve their efficiency and quality. Their key applications include fertilizers, detergents, food industry, water treatment chemicals, metal finishing, and flame retardants material. Fertilizers are the largest application of phosphorus & derivatives, followed by detergents and the food industry. Asia is the largest market for fertilize …
- ダニ媒介脳炎：治療薬の治験動向（2014年下半期）Tick Borne Encephalitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Tick Borne Encephalitis Global Clinical Trials Review, H2, 2014" provides data on the Tick Borne Encephalitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tick Borne Encephalitis. It includes an overview of the trial numbers …
- 使い捨てパンツの世界市場2016-2020About Disposable Undergarment Disposable undergarments refer to underwear, panties, and bras that are used primarily to absorb urine and sweat. These products are also used in gyms and for travel purposes. Disposable undergarments refer to underwear, panties, and bras that are used primarily to absorb urine and sweat. These products are also used in gyms and for travel purposes. Technavio’s analys …
- 香り付きキャンドルの世界市場2017-2021About Scented Candles Scented candles refer to candles that have synthetic or natural scented material blended into them to provide a pleasant smell while burning. Scented candles provide a relaxing environment as a result of the fragrances released while burning. The high sales of scented candles can be attributed to a rapid surge in internet penetration, which has helped connect sellers and buye …
- Mucopolysaccharidosis III (MPS III) (サンフィリッポ症候群)：グローバル臨床試験動向（2014年上半期）Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) clinical trial scenario. This report provides elemental information and data re …
- 航空機内装構造用コア材料の世界市場：ハニカム、フォーム、バルサThe global structural core material market in aerospace interior is projected to grow from USD 142.2 Million in 2016 to USD 220.2 Million by 2021, at a compound annual growth rate (CAGR) of 9.13% during the same period. The structural core material market in aerospace interior is growing because of increasing demand from different applications of aerospace interior. The market witnessed a strong g …
- セキュリティアドバイザリーサービスの世界市場予測（～2024年）The security advisory services market is expected to grow at a CAGR of 19.3% during the forecast period due to the push from regulatory bodies across the globe and increase in adoption of hybrid network environment The global security advisory services market size is expected to grow from USD 7.8 billion in 2019 to USD 18.8 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 19.3% during t …
- 尿排水バッグの世界市場2019-2023About this market Large number of pediatric patients suffering from bladder ailments will drive the global urinary drainage bags market. Urinary tract infections (UTI) occurs when bacteria enters and infects the urinary tract. Bladder infection is the most common type of UTI. Thus, the increase in the number of children suffering from different urinary ailments leads to an increasing need for urin …
- アフターサンケア製品の世界市場：プライスポイント別（マスアフターサン、プレミアムアフターサン）、フォーム別（クリーム、ジェル、ローション、エッセンシャルオイル、その他）、流通経路別（小売薬局、コンビニエンスストア、スーパーマーケット/ハイパーマーケット、Eコマース）After sun care products are used in rehydrating sun burnt skin and are sold in various form such as cream, oil, lotion, and powder. These products are sold through various supply chains such as, retail pharmacies, convenience stores, supermarket/hypermarket and e-commerce. The current scope of the report considers various after sun care products which are sold at mass as well as premium price poin …
- ロシアの心臓血管外科用機器市場見通し（～2021）Russia Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "Russia Cardiovascular Surgery Outlook to 2021", provides key procedures data on the Russia Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dynamic market forecast m …
- 顔認識ソリューションのグローバル市場動向（2014-2018）About Facial Recognition Facial recognition is a biometric software technology that is used for the identification/authentication of individuals. It uses a software application that is specifically designed and developed to automatically identify or authenticate a particular person. The identification/authentication process is carried out by comparing the facial features extracted from an image wi …
- 電気生理学的検査用アブレーションカテーテルのグローバル市場（2014-2018）About Electrophysiology Ablation Catheters Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote irregular cardiac rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias can be of several types, including atrial fibrillation, atrial flutter, and supraventricular tachycardia. Atrial fibrillation is …
- 事業提携・ライセンシング・投資・M&A動向：December 2012（製薬業界）Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report pro …
